Phase 4 Ocular Hypertension Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension
GlaucomaOcular Hypertension
Indiana University50 enrolled1 locationNCT07588152
Recruiting
Phase 4
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
Open Angle GlaucomaOcular Hypertension
Mayo Clinic30 enrolled1 locationNCT07325240
Recruiting
Phase 4
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
Open Angle GlaucomaGlaucomaOcular Hypertension+1 more
University of Miami20 enrolled1 locationNCT07217678
Recruiting
Phase 4
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Glaucoma, Open-AngleOcular Hypertension (OHT)Phacoemulsification Cataract Surgery
Glaukos Corporation132 enrolled1 locationNCT06848946
Recruiting
Phase 4
Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT
Primary Open Angle Glaucoma or Ocular Hypertension
East Coast Institute for Research70 enrolled1 locationNCT06865144
Recruiting
Phase 4
Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells
GlaucomaOcular Hypertension
Rigshospitalet, Denmark28 enrolled2 locationsNCT04957329